Novel phenylthiazoles with a tert-butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties

Mohamed Hagras,Abdelrahman A. Abuelkhir,Nader S. Abutaleb,Ahmed M. Helal,Iten M. Fawzy,Maghawry Hegazy,Mohamed N. Seleem,Abdelrahman S. Mayhoub
DOI: https://doi.org/10.1039/d3ra07619a
IF: 4.036
2024-01-05
RSC Advances
Abstract:The structure–activity relationship of a new tert -butylphenylthiazole series, with a pyrimidine linker, was investigated. We wished to expand knowledge of this novel class of antibiotics by generating 21 new derivatives bearing ≥2 heteroatoms in their side chains. Their activity was examined against isolates of methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile , Escherichia coli , Neisseria gonorrhoeae , and Candida albicans . Two compounds with 1,2-diaminocyclohexane as a nitrogenous side chain showed promising activity against the highly infectious MRSA USA300 strain, with a minimum inhibitory concentration (MIC) of 4 μg mL −1 . One of these two compounds demonstrated potent activity against C. difficile , with a MIC of 4 μg mL −1 . Moderate activities against a C. difficile strain with a MIC of 8 μg mL −1 were noted. Some new compounds possessed antifungal activity against a wild fluconazole-resistant C. albicans strain, with MIC values of 4–16 μg mL −1 . ADME and metabolism-simulation studies were performed for the most promising compound and compared with lead compounds. Our results revealed that one compound possessed greater penetration of bacterial membranes and metabolic resistance, which aided a longer duration of action against MRSA.
chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper aims to solve the problem of antibacterial activity against multi - drug - resistant pathogens (such as methicillin - resistant Staphylococcus aureus MRSA, Clostridium difficile, Escherichia coli, Neisseria gonorrhoeae and Candida albicans), and improve the absorption, distribution, metabolism and excretion (ADME) properties of these compounds. The study explored the structure - activity relationship (SAR) by synthesizing a series of new tert - butyl - containing benzothiazole derivatives, in the hope of finding new antibiotics with stronger antibacterial activity and better pharmacokinetic properties. Specifically, the paper solves the problem through the following points: 1. **Synthesis of new compounds**: Twenty - one new derivatives with two heteroatom - containing side chains were generated. These derivatives have different structural features, especially the nitrogen or oxygen atoms in the side chains. 2. **Antibacterial activity test**: Antibacterial activity tests were carried out on these new compounds, especially against multi - drug - resistant pathogens such as methicillin - resistant Staphylococcus aureus (MRSA), Clostridium difficile, Escherichia coli, Neisseria gonorrhoeae and Candida albicans. 3. **ADME property evaluation**: The ADME properties of the most promising compounds were calculated and simulated to evaluate their metabolic stability and bioavailability in the human body. 4. **Toxicity evaluation**: Cytotoxicity tests were carried out on compounds with potential antibacterial activity to ensure their safety to host tissues. The research results show that two compounds containing 1,2 - diaminocyclohexane as the nitrogen side chain exhibit good antibacterial activity against the highly infectious MRSA USA300 strain, with a minimum inhibitory concentration (MIC) of 4 mg/L. One of these compounds also exhibits strong antibacterial activity against Clostridium difficile, with an MIC value of 4 mg/L. In addition, some compounds also exhibit antifungal activity, with MIC values of 4 - 16 mg/L against wild - type fluconazole - resistant Candida albicans strains. These results provide important clues and a basis for the development of new antibiotics.